1 SWIFT Study: Switching From Lamivudine/Abacavir (3TC/ABC) to Emtricitabine/Tenofovir DF (FTC/TDF) R Campo 1, E DeJesus 2, H Khanlou 3, H Wang 4, K White.
R Campo 1 , E DeJesus 2 , H Khanlou 3 , H Wang 4 , K White 4 ,